Table 2.
Placebo (N = 151) |
Zinc (N = 151) |
Multivitamins (N = 147) |
Multivitamins plus zinc (N = 144) |
|
---|---|---|---|---|
Iron deficiencyb [N (%)] | 13 (8.6) | 23 (15.2) | 7 (4.8) | 11 (7.6) |
Ferritin, μg/L | 48.1 (40.7, 55.4) | 50.7 (43.4, 58.1) | 51.3 (43.8, 58.7) | 51.7 (44.1, 59.2) |
adjusted for α-1-acid glycoprotein | 47.8 (40.8, 54.9) | 51.5 (43.9, 58.2) | 51.3 (44.1, 58.6) | 51.3 (44.1, 58.6) |
Soluble transferrin receptor, mg/L | 1.8 (1.7, 2.0) | 1.8 (1.7, 2.0) | 1.7 (1.5, 1.8) | 1.8 (1.6, 1.9) |
Values are N (%) or means with 95%CI from ANOVA models.
Iron deficiency was defined as ferritin < 12 μg/L or, where α-1-acid-glycoprotein ≥ 1.0 g/L, soluble transferrin receptor > 8.3 mg/L.
Comparison of iron deficiency prevalence among treatment arms: χ2(3) = 10.62, p = .014.